Home › Business & Finance › Nvidia-Backed AI Biotech Iambic Up 16% After $150 Million IPO
Business & Finance

Nvidia-Backed AI Biotech Iambic Up 16% After $150 Million IPO

Key Points

Iambic Therapeutics Inc. shares soared 16% in its trading debut after the clinical-stage cancer drugmaker and technology firm raised $150 million in a US initial public offering.

Iambic Therapeutics Inc. shares soared 16% in its trading debut after the clinical-stage cancer drugmaker and technology firm raised $150 million in a US initial public offering.
Nvidia-Backed AI Biotech Iambic (ORG) Therapeutics Inc. (ORG) US (LOCATION)
Originally published by Bloomberg Markets Read original →